← European Medicine Shortage Tracker · all medicines

Lattulosio shortage — availability across Europe

Lattulosio currently has availability issues reported in 1 European register: Italy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Shortage  ATC — · also listed as: LATTULOSIO · data refreshed 7 August 2026

Key facts

As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Lattulosio, covering 3 affected product presentations. The longest-running open report was filed in Italy on 2023-03-27 and has now been open for about 41 months. Where agencies state a cause, unexpectedly high demand lead with 2 of the 3 stated-cause reports, followed by manufacturing problems with 1. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. Registers in Italy indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇹 ItalyShortage
LATTULOSIO AUROBINDO
+ 2 more products
LATTULOSIO SANDOZ
LATTULOSIO ZENTIVA
2023-03-27Elevata richiesta
Alternatives: AIFA: equivalents with the same active substance are available.
register ↗

Full report history (3 register entries)

Every individual register entry for Lattulosio in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇹 ITLATTULOSIO SANDOZShortage2026-09-24Elevata richiesta
🇮🇹 ITLATTULOSIO AUROBINDOShortage2026-06-14Elevata richiesta
🇮🇹 ITLATTULOSIO ZENTIVAShortage2023-03-27Problemi produttivi

Frequently asked

Is Lattulosio currently in shortage in Europe?

Yes. As of 7 August 2026, availability issues are reported in: Italy. Availability is national — a shortage in one country does not mean it is short everywhere.

Are there alternatives to Lattulosio?

3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Lattulosio availability data come from?

Directly from the official medicines-agency register that lists Lattulosio: AIFA (Italy). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Lattulosio — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lattulosio/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Lattulosio availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/lattulosio/">Lattulosio shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Lattulosio: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 7 August 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.